Mirati Therapeutics, Inc.

NASDAQ: MRTX
$83.05
+$0.96 (+1.2%)
Closing price August 10, 2022
Tuesday’s additional top analyst upgrades and downgrades were on BHP, Booz Allen Hamilton, Devon Energy, Mirati Therapeutics, Novo Nordisk, NRG Energy and more.
Tuesday afternoon's top analyst upgrades and downgrades included Coupa Software, Ginkgo Bioworks, Enterprise Products Partners and Intuit.
Tuesday's top analyst upgrades and downgrades included BioNTech, ConocoPhillips, Harley-Davidson, Livent, Luminar Technologies, Meta Platforms, Moderna, Snap, Twitter, United Airlines, US Foods,...
Thursday's top analyst upgrades and downgrades included Dick’s Sporting Goods, Fate Therapeutics, Kimberly-Clark, Nordstrom, Roblox, TJX Companies and Zoom Video Communications.
Monday's top analyst upgrades and downgrades included Foot Locker, Halozyme Therapeutics, Kimberley-Clark, Occidental Petroleum, Texas Roadhouse, Trip.com and Williams Companies.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including At Home, Beyond Meat, Lyft, MoneyGram and Raytheon Technologies.
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, Asana, Baidu, First Solar, Mattel, Mirati Therapeutics, Palantir Technologies, Pinterest, SAP and Zscaler.